NCT00429572View on ClinicalTrials.gov

Mini-Allogeneic Peripheral Blood Progenitor Cell Transplantation For Recurrent or Metastatic Breast Cancer

PHASE2CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

January 31, 1998

Primary Completion Date

May 31, 2008

Study Completion Date

May 31, 2008

Conditions

Breast Cancer

Interventions

DRUG

Fludarabine

30 mg/m\^2 intravenously Daily for 5 Days

DRUG

Melphalan

70 mg/m\^2 intravenously Daily for 2 Days

PROCEDURE

Stem Cell Infusion

Stem Cell Infusion on Day 0.

Trial Locations (1)

77030

U.T.M.D. Anderson Cancer Center, Houston

All Listed Sponsors

lead

M.D. Anderson Cancer Center

OTHER

NCT00429572 - Mini-Allogeneic Peripheral Blood Progenitor Cell Transplantation For Recurrent or Metastatic Breast Cancer | Biotech Hunter | Biotech Hunter